Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut - WSJ
Merck struggles to win European approval for Covid antiviral pill | Financial Times
Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says - Bloomberg
Explainer: How does Merck's COVID-19 pill compare to Pfizer's? | Reuters
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Merck Says Its Covid Pill Is Less Effective in a Final Analysis - The New York Times
Merck: Experimental Pill Treats COVID-19 at Earliest Stages | St Vincents Medical Center
Pfizer COVID pill approved in Japan, following Merck treatment - Nikkei Asia
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
Merck's COVID pill loses its lustre: what that means for the pandemic
Merck | Home
Canada enters deals to procure Merck and Pfizer's Covid-19 antiviral pills
Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be used
Molnupiravir: Merck's Covid-19 antiviral less effective in new analysis - Pharmaceutical Technology
Merck's Covid Pill Might Pose Risks for Pregnant Women - The New York Times
Study: Merck's COVID-19 drug reduces hospitalization risk | Coronavirus | wkow.com
FDA advisory panel narrowly recommends Merck's Covid pill for emergency use
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
Merck Seeks FDA Authorization for First COVID-19 Pill | Everyday Health
Merck's new COVID drug molnupiravir gets FDA consideration : Shots - Health News : NPR
Merck signs deal to supply Singapore with its Covid-19 antiviral pill
